Speakers | Kisaco Research

Speakers

Women's Health Innovation Summit 2024
23-25 September, 2024
Boston, MA, USA
  • Author:

    Trish Costello

    Founder & CEO
    Portfolia

    Ms. Costello is founder and CEO of Portfolia, which offers a radically different investing process designed for women and other emerging investors. She is also co-founder and CEO Emeritus of the Kauffman Fellows Program, Center for Venture Education, the global educational institute preparing the leaders of the venture capital industry, located in Palo Alto, CA. Portfolia brings investing into the 21st Century, creating entrepreneurial funds focused where women make markets, such as women's health, active aging, consumer, enterprise, food & agtech, and fashion, tech and beauty. The investing experience is smart, personalized, and educational, providing returns and market impact customized to your interests. Portfolia is building a powerful global community of sophisticated investors focusing their money and influence to build the world they want.

    Trish Costello

    Founder & CEO
    Portfolia

    Ms. Costello is founder and CEO of Portfolia, which offers a radically different investing process designed for women and other emerging investors. She is also co-founder and CEO Emeritus of the Kauffman Fellows Program, Center for Venture Education, the global educational institute preparing the leaders of the venture capital industry, located in Palo Alto, CA. Portfolia brings investing into the 21st Century, creating entrepreneurial funds focused where women make markets, such as women's health, active aging, consumer, enterprise, food & agtech, and fashion, tech and beauty. The investing experience is smart, personalized, and educational, providing returns and market impact customized to your interests. Portfolia is building a powerful global community of sophisticated investors focusing their money and influence to build the world they want.

  • Author:

    Jennifer Schneiders

    President Diagnostic Solutions
    Hologic

    Jennifer Schneiders

    President Diagnostic Solutions
    Hologic
  • Author:

    Hadine Joffee

    MD, MSc, Interim Chair, Department of Psychiatry, Executive Director, Mary Horrigan Connors Center for Women's Health and Gender Biology
    Brigham and Women’s Hospital & Harvard Medical School

    Hadine Joffee

    MD, MSc, Interim Chair, Department of Psychiatry, Executive Director, Mary Horrigan Connors Center for Women's Health and Gender Biology
    Brigham and Women’s Hospital & Harvard Medical School
  • Author:

    Shefali Goyal MS, MSc

    Vice President, Head of Global RA Strategy and US Regulatory Affairs
    Organon

    Shefali Goyal MS, MSc

    Vice President, Head of Global RA Strategy and US Regulatory Affairs
    Organon
  • Author:

    Monica Garcia

    Assistant Director, Obstetrical and Reproductive Health Devices Team, CDRH,
    FDA

    Monica Garcia

    Assistant Director, Obstetrical and Reproductive Health Devices Team, CDRH,
    FDA
  • Author:

    Nichole YoungLin

    MD, MBA, Women’s Health Clinical Lead
    Google

    Nichole YoungLin

    MD, MBA, Women’s Health Clinical Lead
    Google
  • Author:

    Patricia Obermaier

    Chief Growth Officer, Global Health and Life Sciences
    Microsoft

    Patricia Obermaier

    Chief Growth Officer, Global Health and Life Sciences
    Microsoft
  • Author:

    Asima Ahmad

    Co-Founder & Chief Medical Officer
    Carrot Fertility

    Asima Ahmad

    Co-Founder & Chief Medical Officer
    Carrot Fertility
  • Author:

    Dr. Neel Shah

    Chief Medical Officer
    Maven Clinic

    Dr. Neel Shah

    Chief Medical Officer
    Maven Clinic
  • Author:

    Carolee Lee

    Founder & CEO
    WHAM (Women's Health Access Matters)

    Carolee Lee is an innovator, entrepreneur and thought leader dedicated to improving women’s health and wellbeing, and their opportunities to succeed. She was founder and CEO of Carolee Designs, one of the world’s leading accessories brands. Carolee launched WHAM (Women’s Health Access Matters), a nonprofit organization working to bring awareness and funding to women’s health research to transform women’s lives. Carolee forged a research partnership with the RAND Corporation to create The WHAM Report, the first study to analyze the economic costs, benefits and social impacts of health research that focuses specifically on women. The WHAM Report is changing the conversation around women’s health research, proving women’s health research is an economic issue we cannot afford to ignore. Through partnerships with leading advocacy groups, business leaders, researchers and economists, WHAM is using this data drive change.

     

    Carolee is also a mentor and leader in business, philanthropic and educational organizations. She is a past Chair and Foundation Board Chair of the Committee of 200, a community of the most successful women in business, and has served as director on the board of DSW, Inc. Carolee is a founding board member of The Breast Cancer Research Foundation, where she has served since 1986. She currently sits on the Women’s Leadership Board at The John F. Kennedy School of Government at Harvard University.

    Carolee Lee

    Founder & CEO
    WHAM (Women's Health Access Matters)

    Carolee Lee is an innovator, entrepreneur and thought leader dedicated to improving women’s health and wellbeing, and their opportunities to succeed. She was founder and CEO of Carolee Designs, one of the world’s leading accessories brands. Carolee launched WHAM (Women’s Health Access Matters), a nonprofit organization working to bring awareness and funding to women’s health research to transform women’s lives. Carolee forged a research partnership with the RAND Corporation to create The WHAM Report, the first study to analyze the economic costs, benefits and social impacts of health research that focuses specifically on women. The WHAM Report is changing the conversation around women’s health research, proving women’s health research is an economic issue we cannot afford to ignore. Through partnerships with leading advocacy groups, business leaders, researchers and economists, WHAM is using this data drive change.

     

    Carolee is also a mentor and leader in business, philanthropic and educational organizations. She is a past Chair and Foundation Board Chair of the Committee of 200, a community of the most successful women in business, and has served as director on the board of DSW, Inc. Carolee is a founding board member of The Breast Cancer Research Foundation, where she has served since 1986. She currently sits on the Women’s Leadership Board at The John F. Kennedy School of Government at Harvard University.

  • Author:

    Elizabeth Cherot

    MD, MBA, Chief Medical Officer
    March of Dimes

    Elizabeth Cherot

    MD, MBA, Chief Medical Officer
    March of Dimes
  • Author:

    Jason Roberts

    Gynecological and Surgical Devices, CDRH,
    FDA

    Jason Roberts

    Gynecological and Surgical Devices, CDRH,
    FDA
  • Author:

    Michael Annichine

    CEO
    Magee-Womens Research Institute

    Michael Annichine

    CEO
    Magee-Womens Research Institute
  • Author:

    Alice Zheng, MD, MBA, MPH

    Principal
    RH Capital

    Alice Zheng, MD, MBA, MPH

    Principal
    RH Capital
  • Author:

    Diana Torgersen

    Executive Director, External Innovation & Emerging Science
    Organon

    Diana Torgersen

    Executive Director, External Innovation & Emerging Science
    Organon
  • Author:

    Lisa Suennen

    Managing Partner, AHA Ventures
    American Heart Association

    Lisa Suennen

    Managing Partner, AHA Ventures
    American Heart Association
  • Author:

    Daniel Johnston

    Chief, Contraception Research Branch
    Eunice Kennedy Shriver National Institute of Child Health and Human Development

    Daniel Johnston

    Chief, Contraception Research Branch
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Author:

    Laura Clark-Kelly

    Senior Director of Value & Reimbursement
    Harmony Biosciences

    Laura Clark-Kelly

    Senior Director of Value & Reimbursement
    Harmony Biosciences
  • Author:

    Greg Singleton

    Chief Artificial Intelligence Officer
    US Department of Health & Human Services

    Greg Singleton

    Chief Artificial Intelligence Officer
    US Department of Health & Human Services
  • Author:

    Piraye Beim

    Founder & CEO
    Celmatix

    Piraye Beim

    Founder & CEO
    Celmatix
  • Author:

    Everett Handford

    MBA, Regional Director, New England US Department of Health
    Human Services

    Everett Handford

    MBA, Regional Director, New England US Department of Health
    Human Services
  • Author:

    Natalie Buford-Young

    CEO
    Springboard Enterprises

    Natalie Buford-Young

    CEO
    Springboard Enterprises
  • Author:

    Nada Hanafi MSc, MPH

    Founder & Manager, MedTech Strategy Advisors LLC; Co-Founder
    MedTech Color

    Nada Hanafi MSc, MPH

    Founder & Manager, MedTech Strategy Advisors LLC; Co-Founder
    MedTech Color
  • Author:

    Susan Nicholson

    MD, FIDSA, Board Member
    ASPIVIX

    Susan Nicholson

    MD, FIDSA, Board Member
    ASPIVIX
  • Author:

    Roslyn Holliday Moore

    Deputy Director for Programs
    Office of Behavioral Equity, US Department of Health and Human Services

    Roslyn Holliday Moore

    Deputy Director for Programs
    Office of Behavioral Equity, US Department of Health and Human Services
  • Author:

    Jasmi Shah

    Managing Director
    Cigna Ventures

    Jasmi Shah

    Managing Director
    Cigna Ventures
  • Author:

    Jacqueline Oliveira-Cella

    Founder
    wellBe Consulting

    Jacqueline Oliveira-Cella

    Founder
    wellBe Consulting
  • Author:

    Lisa Marceau

    President & Founder, Millennial Health
    CEO & Founder, Joyuus

    Lisa Marceau

    President & Founder, Millennial Health
    CEO & Founder, Joyuus
  • Author:

    Ariel Kramer

    President & Founder
    Klover Communications

    Ariel Kramer

    President & Founder
    Klover Communications
  • Author:

    Valerie Palmieri

    CEO
    MOMENTUM Consulting

    Valerie Palmieri

    CEO
    MOMENTUM Consulting
  • Author:

    Rachel Braun Scherl

    Business Builder, Marketing Strategist, Vagipreneur
    SPARK Solutions for Growth

    Rachel Braun Scherl

    Business Builder, Marketing Strategist, Vagipreneur
    SPARK Solutions for Growth
  • Author:

    Maryon Stewart BEM

    CEO and Founder
    Femmar Health

    Maryon Stewart BEM

    CEO and Founder
    Femmar Health
  • Author:

    Ivana Munci-Vasic

    CEO & Founder
    Vitra Labs

    Ivana Munci-Vasic

    CEO & Founder
    Vitra Labs
  • Author:

    Erkeda DeRouen

    CEO & Principal Consultant
    Digital Risk Compliance Solutions

    Erkeda DeRouen

    CEO & Principal Consultant
    Digital Risk Compliance Solutions
  • Author:

    Brianna Brennan

    Chief Innovation Officer
    Ontrak Health

    Brianna Brennan

    Chief Innovation Officer
    Ontrak Health
  • Author:

    Claire Gill

    CEO
    Bone Health & Osteoporosis Foundation

    Claire Gill

    CEO
    Bone Health & Osteoporosis Foundation
  • Author:

    Emilė Radyte

    Co-Founder & CEO
    Samphire Neuroscience

    Emilė Radyte

    Co-Founder & CEO
    Samphire Neuroscience
  • Author:

    Mira Kaufman

    Investment Team
    Ingeborg Investment

    Mira Kaufman

    Investment Team
    Ingeborg Investment
  • Author:

    Rachel Robinson

    Chief Operating Officer
    MassMedic

    Rachel Robinson

    Chief Operating Officer
    MassMedic
  • Author:

    Saranya Loehrer MD, MPH

    Chief Health Equity Officer
    Teldoc Health

    Saranya Loehrer MD, MPH

    Chief Health Equity Officer
    Teldoc Health
  • Author:

    Tamika Lane, MSN, RN, CCM

    Director, Clinical Innovation and Client Relationships
    Sentara Health Plans

    Tamika Lane, MSN, RN, CCM

    Director, Clinical Innovation and Client Relationships
    Sentara Health Plans
  • Author:

    Andrea Olariu

    CEO
    Medicines360

    Andrea Olariu

    CEO
    Medicines360
  • Author:

    Cory Warner

    Global Head of Customer Growth and Operations
    Uber Health

    Cory Warner

    Global Head of Customer Growth and Operations
    Uber Health
  • Author:

    Lucy Perez

    PhD, Senior Principal
    McKinsey & Company

    Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

    Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

    Lucy Perez

    PhD, Senior Principal
    McKinsey & Company

    Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

    Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

  • Author:

    Anula Jayasuriya

    Co-Founder
    Kidron Capital

    Anula Jayasuriya

    Co-Founder
    Kidron Capital
  • Author:

    Madison Soucie

    Co-Founder
    Alpha Millennial Health

    Madison Soucie

    Co-Founder
    Alpha Millennial Health
  • Author:

    Zeynep Sabah Bagwell

    Head of Personal Care
    42 Technology

    Zeynep Sabah Bagwell

    Head of Personal Care
    42 Technology
  • Author:

    Tracy Warren

    Manager
    Healthwormx Ventures

    Tracy Warren

    Manager
    Healthwormx Ventures
  • Author:

    Sarah Knight

    Head of Healthcare Technology
    42 Technology

    Sarah Knight

    Head of Healthcare Technology
    42 Technology
  • Author:

    Sabrina Martucci Johnson

    President and CEO
    DARÉ Bioscience

    Sabrina Martucci Johnson is a life sciences executive with a record of achievement in building successful companies, launching innovative products into specialty markets, delivering returns on shareholder investments, and implementing complex directional change.   

     

    Sabrina is committed to advancing innovation in women’s health. She is the Founder and CEO of DARÉ Bioscience (NASDAQ:DARE), a clinical-stage biopharmaceutical company driven by a mission to identify, develop and bring to market a diverse portfolio of novel therapies that expand treatment options, improve outcomes and facilitate convenience for women.  Prior to founding DARÉ, Sabrina was President of WomanCare Global Trading, a global provider of women’s health products, CFO/CAO of the California Institute for Biomedical Research, CFO/COO of Cypress Bioscience, Inc. (NASDAQ:CYPB), held marketing and sales positions with Advanced Tissue Sciences, and began her career in the biotechnology industry as a research scientist with Baxter Healthcare, Hyland Division, working on the recombinant factor VIII program.  

     

    Sabrina has a Master of International Management with honors from the American Graduate School of International Management (Thunderbird); a MSc. in Biochemical Engineering from the University of London, University College London; and a BSc. in Biomedical Engineering from Tulane University, magna cum laude.  

     

    Sabrina currently serves on the boards of ATAI Life Sciences, a publicly-traded clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, and Aethlon Medical, Inc., a publicly-traded company developing immunotherapeutic technologies to combat infectious disease and cancer, BIOCOM, as Vice President of Industry, the Clearity Foundation as Chair, and the YWCA of San Diego County as Past President. Additionally, Sabrina serves on the Board of Advisors of Tulane University School of Science & Engineering and on the Audit Committee of Project Concern International. 

    Ms. Johnson was honored by Athena, a San Diego-based business organization championing women executives and rising managers in science, technology, engineering and mathematics, with the Individual in Life Science award in 2017 and the same year received the “Moxie” for her grit and determination and positive impact in the community from the award-winning MOXIE Theatre, a Southern California theatre dedicated to producing diverse and honest images of women using the art of theatre.  She was an E&Y Entrepreneur of the Year San Diego finalist in 2018 and in 2019 was recognized as an entrepreneur in the PharmaVoice 100 and honored as 2019 Director of the Year in the Emerging Board Leader category by the San Diego Corporate Directors Forum. 

    Sabrina Martucci Johnson

    President and CEO
    DARÉ Bioscience

    Sabrina Martucci Johnson is a life sciences executive with a record of achievement in building successful companies, launching innovative products into specialty markets, delivering returns on shareholder investments, and implementing complex directional change.   

     

    Sabrina is committed to advancing innovation in women’s health. She is the Founder and CEO of DARÉ Bioscience (NASDAQ:DARE), a clinical-stage biopharmaceutical company driven by a mission to identify, develop and bring to market a diverse portfolio of novel therapies that expand treatment options, improve outcomes and facilitate convenience for women.  Prior to founding DARÉ, Sabrina was President of WomanCare Global Trading, a global provider of women’s health products, CFO/CAO of the California Institute for Biomedical Research, CFO/COO of Cypress Bioscience, Inc. (NASDAQ:CYPB), held marketing and sales positions with Advanced Tissue Sciences, and began her career in the biotechnology industry as a research scientist with Baxter Healthcare, Hyland Division, working on the recombinant factor VIII program.  

     

    Sabrina has a Master of International Management with honors from the American Graduate School of International Management (Thunderbird); a MSc. in Biochemical Engineering from the University of London, University College London; and a BSc. in Biomedical Engineering from Tulane University, magna cum laude.  

     

    Sabrina currently serves on the boards of ATAI Life Sciences, a publicly-traded clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, and Aethlon Medical, Inc., a publicly-traded company developing immunotherapeutic technologies to combat infectious disease and cancer, BIOCOM, as Vice President of Industry, the Clearity Foundation as Chair, and the YWCA of San Diego County as Past President. Additionally, Sabrina serves on the Board of Advisors of Tulane University School of Science & Engineering and on the Audit Committee of Project Concern International. 

    Ms. Johnson was honored by Athena, a San Diego-based business organization championing women executives and rising managers in science, technology, engineering and mathematics, with the Individual in Life Science award in 2017 and the same year received the “Moxie” for her grit and determination and positive impact in the community from the award-winning MOXIE Theatre, a Southern California theatre dedicated to producing diverse and honest images of women using the art of theatre.  She was an E&Y Entrepreneur of the Year San Diego finalist in 2018 and in 2019 was recognized as an entrepreneur in the PharmaVoice 100 and honored as 2019 Director of the Year in the Emerging Board Leader category by the San Diego Corporate Directors Forum. 

  • Author:

    Lynn Falconio

    Board Member
    NAYA Biosciences

    Lynn Falconio

    Board Member
    NAYA Biosciences
  • Author:

    Jennifer Lahey

    Talent Optimization Consultant
    Predictive Success Corporation

    Jennifer Lahey

    Talent Optimization Consultant
    Predictive Success Corporation
  • Author:

    Flavia Mason

    Global Vice President, Women's Health
    Perrigo

    Flavia Mason

    Global Vice President, Women's Health
    Perrigo
  • Author:

    Eva Temkin

    Former FDA Counsel and Acting Director for Policy
    FDA Office of Therapeutic Biologics

    Eva Temkin

    Former FDA Counsel and Acting Director for Policy
    FDA Office of Therapeutic Biologics